Literature DB >> 7925387

Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.

H Atoda1, N Yoshida, M Ishikawa, T Morita.   

Abstract

The binding properties of the coagulation factor IX/factor X-binding anticoagulant protein (IX/X-bp) isolated from the venom of Trimeresurus flavoviridis (habu snake) were investigated with an enzyme-linked immunosorbent assay. The half-maximal binding and maximal binding of IX/X-bp to both factors IX and X were observed at concentrations of Ca2+ ions of 0.4 mM and 1 mM, respectively. Concentration of IX/X-bp at half-maximal binding to solid-phase bovine factor IX and solid-phase bovine factor X were 0.4 +/- 0.1 nM and 1.1 +/- 0.4 nM, respectively, in the presence of 1 mM Ca2+ ions. The kinetics of binding activity of IX/X-bp to bovine factors IXa and Xa and to human factors IX and X resembled those of the binding to bovine factors IX and X. IX/X-bp did not bind to solid-phase coagulation factors other than factor IX/IXa and factor X/Xa, for example, prothrombin, factor VII, protein C, and protein Z, under the conditions of the experiment. To localize the binding sites of IX/X-bp on the coagulation factors, the ability of IX/X-bp to bind to various fragments derived from factors IX and X was examined. The binding of IX/X-bp to solid-phase factor IX was inhibited by a peptide containing the 4-carboxyglutamic acid (Gla) domain derived from factor IXa beta' (residues 1-42) in the liquid phase, but the binding was not inhibited by Gla-domainless factor IXa beta'. Half-maximal binding of IX/X-bp to solid-phase Gla-domain peptide of factor IX occurred at 9.2 +/- 1.9 nM. Factor X was partially reduced and the S-carboxymethylated light and heavy chains of factor X were prepared. IX/X-bp bound to the S-carboxymethylated light chain of factor X but not to the heavy chain. The binding of IX/X-bp to solid-phase factor X was inhibited by the Gla-domain peptide of factor X (residues 1-44) but not by Gla-domainless factor X. IX/X-bp bound to PCGFX, a recombinant human protein C whose Gla-domain region (residues 1-43) had been replaced by residues 1-43 of human factor X. The affinity of binding was about one tenth of that to intact human factor X. IX/X-bp was unable to bind at all to human protein C. These data indicate that IX/X-bp is a protein that binds to the Gla-domain regions of factors IX and X in the presence of Ca2+ ions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925387     DOI: 10.1111/j.1432-1033.1994.t01-1-00703.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

Review 1.  Snake venoms.

Authors:  F S Markland
Journal:  Drugs       Date:  1997       Impact factor: 9.546

2.  Characterization of bothrojaracin interaction with human prothrombin.

Authors:  R Q Monteiro; P E Bock; M L Bianconi; R B Zingali
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

3.  Identification of inhibitors of α2β1 integrin, members of C-lectin type proteins, in Echis sochureki venom.

Authors:  Piotr Jakubowski; Juan J Calvete; Johannes A Eble; Philip Lazarovici; Cezary Marcinkiewicz
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-13       Impact factor: 4.219

Review 4.  Use of snake venom inhibitors in studies of the function and tertiary structure of coagulation factors.

Authors:  Takashi Morita
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

Review 5.  Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving.

Authors:  Tarek Mohamed Abd El-Aziz; Antonio Garcia Soares; James D Stockand
Journal:  Toxins (Basel)       Date:  2019-09-25       Impact factor: 4.546

6.  Effects of hemocoagulase agkistrodon on the coagulation factors and its procoagulant activities.

Authors:  Haixin Li; Ying Huang; Xian Wu; Ting Wu; Ying Cao; Qimei Wang; Yuchang Qiu; Weiming Fu; Qun Zhang; Jianxin Pang
Journal:  Drug Des Devel Ther       Date:  2018-05-23       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.